Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > Clinical trials for medicines: apply for authorisation in the UK

https://www.gov.uk/guidance/clinical-trials-for-medicines-apply-for-authorisation-in-the-uk#full-publication-update-history

Philippe Calandra 24 January 2022 All news
  • ← Changes to the guidance document Temporary authorisation of human medicinal products HMV4
  • Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022 →

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • China : release of MedDRA Coding Guidance for Adverse DrugReaction (ADR) Reports
  • Medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency
  • Questions and Answers Regarding the Implementation of a Risk-Prioritized Periodic Safety Update Report Regulatory Review Pilot (PSUR-RRP) at Health Canada
Copyright © 2018 - Pharmya - Legal terms - Quality Policy